IEL (524614)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹6.13 |
| Market Cap | ₹20.53 Cr |
| P/E Ratio | 0 |
| ROCE | 2.51% |
| ROE | -37.28% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹5.15 — ₹10.28 |
| Sector | Food Products |
| Book Value | ₹0.14 |
Strengths
- Piotroski F-Score of 7/9 suggests some recent improvement in financial health.
- ROCE is positive at 2.51%, indicating operations generate at least some capital return.
- Latest quarter shows net profit of ₹0 crore, so there is no immediate loss expanding further.
- Small market cap of ₹21 crore and low absolute price may attract speculative attention, though this is not fundamental value.
Concerns
- Price-to-book of 43.79 against a book value of ₹0.14 per share leaves no margin of safety.
- ROE is deeply negative at -37.28%, meaning shareholder equity is being eroded.
- Sales growth and profit growth are both 0.00%, with no visible growth engine.
- No dividend yield, no positive earnings to justify a P/E, and promoter holding data is unavailable.
AI Analysis
As a value investor, I look for companies that give me a margin of safety. IEL fails that test on almost every measurable figure. The current price of ₹6.13 gives a market cap of just ₹21 crore, but the book value per share is only ₹0.14. That means I am paying about 44 times the net worth on the books. Meanwhile, the company is losing money on equity, with ROE at -37.28%, and its latest quarter produced sales of ₹1 crore and net profit of ₹0 crore. There is no sales growth, no profit growth, and no dividend to compensate me while I wait. In Graham's language, if the balance sheet shows barely any net assets and the income statement shows no earnings, there is no underlying value for me to anchor to. The Piotroski F-Score of 7/9 is the only encouraging signal, and it does suggest some improvement in financial health. But a positive F-Score cannot replace actual profitability. ROCE is only 2.51%, far below what I want from an operating business. The 52-week trading range, from ₹4.50 to ₹10.28, tells me this is a speculative small-cap whose price can move for reasons unrelated to fundamentals. At 43.79 times book, with negative ROE and zero growth, the valuation is not based on current value or earnings; it is based on hope. This is a possible turnaround story, but as an investor, I need evidence, not hope. I would wait for sustained positive net profits, visible sales growth, and a better price-to-book relationship before committing even a small amount of capital. A good business is not one with a high share price; it is one that earns a decent return on the money invested in it. IEL is not there yet.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer